Harrison.ai Secures $32 Million in Funding
Harrison.ai, a Sydney, Australia-based global healthtech company specializing in AI solutions for the medical sector, has raised $32 million in funding.
Harrison.ai, a Sydney, Australia-based global healthtech company specializing in AI solutions for the medical sector, has raised $32 million in funding.
Investor
The National Reconstruction Fund Corporation (NRFC) made this equity investment part of Harrison.ai’s Series C funding round.
The NRFC is an Australian government-backed organization with $15 billion to invest through direct loans, equity investments, and loan guarantees. The fund focuses on seven priority areas: value-added resources, transport, medical science, defense capability, renewables and low-emission technologies, value-added agriculture, and enabling capabilities.
Harrison.ai Use of Funds
The investment will enable Harrison.ai to develop its AI-driven radiology and pathology diagnostic technologies further, strengthen its Australian operations, and support its global expansion efforts.
About Harrison.ai
Harrison.ai offers AI-powered diagnostic support and workflow solutions designed to assist healthcare professionals in diagnosing medical conditions such as cancer. Their technology leverages AI to analyze medical imaging, including CT scans and X-rays. The company’s solutions are used in over 1,000 healthcare facilities worldwide, including the UK's National Health Service.
Funding Details
Company: Harrison-AI Pty Ltd
Raised: $32.0M
Round: Series C
Funding Date: January 2025
Investor: The National Reconstruction Fund Corporation
Company Website: https://harrison.ai/
Software Category: AI Diagnostic Support and Workflow Solutions
